Cure8 research brief
Metabolic syndrome appears common in this Tunisian IBD cohort (about one-third). MetS can affect overall health and may influence long-term outcomes for people with IBD, so awareness and cardiometabolic screening may be relevant.
Adult IBD patients, gastroenterologists, primary care clinicians involved in cardiometabolic risk management, and researchers focused on IBD comorbidities and population health in North Africa.
This is a retrospective, cross-sectional study of 161 IBD patients (both Crohn’s disease and ulcerative colitis) seen between 1998–2025. Using modified NCEP ATP III criteria the authors found MetS in about one-third of patients (32.3%), with similar rates in CD and UC. Older age was associated with MetS in multivariable analysis.
The paper examines relationships between MetS and clinical, biological, radiological, and treatment-related variables from medical records. Because the source content is an abstract-level preprint, details such as exact statistical adjustments, definitions of outcomes, or causal inferences are limited in the text provided.
Preprint abstract from Europe PMC; study is retrospective and cross-sectional from one center, so results may not generalize. The abstract provides limited methodological and outcome details—interpret as preliminary until full peer-reviewed publication.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Skin disease (hidradenitis suppurativa) may be more common in people with IBD—particularly Crohn disease—and could be linked with more severe intestinal complications. Awareness can prompt coordinated care between...
This meta-analysis suggests people with IBD face higher risks of major cardiovascular events (heart attack, ischemic heart disease, ischemic stroke), which may matter for monitoring and preventive care. Higher risk...
This large, population-based study suggests people with Crohn's disease have modestly higher overall mortality than matched controls and higher deaths from specific causes (colorectal cancer, renal disease, non-Hodgkin...
